Hithanadura Janaka De Silva

Prof. Hithanadura Janaka De Silva


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2021 in Toxicon: X
Verified
Journal Article
Open access
AKAnuradhani Kasturiratne
Anuradhani Kasturiratne
DLDavid G. Lalloo
David G. Lalloo
HSHithanadura Janaka De Silva
Hithanadura Janaka De Silva
The burden of disability among survivors and the socio-economic impact of snakebite have not been adequately researched. We reviewed original research articles, case reports and small case series relating to chronic physical, mental and psycho-social disability and economic burden of snakebite. Both physical and psychological health problems seem common in snakebite survivors and can lead to disability and loss of productivity. Chronic physical health effects, musculoskeletal disability being the commonest, can be largely attributed to limited and delayed access to optimal treatment of acute envenoming. The economic burden is considerable, and includes health system costs, out-of-pocket expenditure and opportunity costs, with regional variations. Health systems should be more responsive to needs and circumstances of bite victims, and a more holistic approach should be developed in the treatment of snakebite which incorporates the management of chronic health effects.

15 June 2022 in Clinical and Experimental Pediatrics
Verified
Journal Article
Open access
PDF file
TRThushara Rodrigo
Thushara Rodrigo
SDSamaranayake Dulani
Samaranayake Dulani
SSSumudu Nimali Seneviratne
Sumudu Nimali Seneviratne
ASArjuna P. De Silva
Arjuna P. De Silva
JFJerad Fernando
Jerad Fernando
VWV. Pujitha Wickramasinghe
V. Pujitha Wickramasinghe
Background: Childhood obesity is a global problem associated with metabolic abnormalities. The gut-liver axis is thought to play a major role in its pathogenesis. Probiotics are known to alter the gut microbiota and, therefore, could be a therapeutic option in the management of childhood obesity-related complications.Purpose: This double-blind randomized placebo-controlled trial evaluated the effects of probiotics on metabolic derangement in obese children with nonalcoholic fatty liver disease/ nonalcoholic steatohepatitis (NAFLD/NASH).Methods: Obese children with NAFLD/NASH treated at the nutrition clinic of the University Paediatric Unit at Lady Ridgeway Hospital, Colombo, were recruited. Anthropometry, body fat, metabolic derangement, and liver ultrasound scan (USS) results were evaluated at baseline and after 6 months. Transient elastography (FibroScan) was performed on a subsample of these patients. Eighty-four patients were recruited and randomized into the probiotics (n=43) and placebo (n= 41) groups. The mean age was 11.3±1.9 versus 12.1±1.5 years in the probiotic and placebo groups, respectively. Baseline parameters including liver disease stage on USS, body fat percentage, fasting blood sugar, lipid profile, liver function, and C-reactive protein showed no significant intergroup differences.Results: In the probiotic group, a statistically significant reduction in body mass index was noted from the baseline value. However, the reduction was not significant compared with the placebo group. There was a significant reduction in triglycerides, aspartate transaminase (AST), alanine aminotransferase (ALT), AST/ALT ratio, and alkaline phosphatase in the placebo group over the treatment period. Although the liver disease stage on USS improved from stage II–III to stage I in a small number of patients in the probiotic-treated group, transient elastography performed in a subsample did not demonstrate significant improvement in either group.Conclusion: Our results indicate that probiotics have no advantage over lifestyle modification for improving obesityassociated metabolic derangement in children.

1 March 2021 in European Journal of Radiology
Verified
Journal Article
Closed access
MNMadunil Anuk Niriella
Madunil Anuk Niriella
DEDileepa Senajith Ediriweera
Dileepa Senajith Ediriweera
AKAnuradhani Kasturiratne
Anuradhani Kasturiratne
DGDeepa Gunasekara
Deepa Gunasekara
SSShamila Thivanshi De Silva
Shamila Thivanshi De Silva
HSHithanadura Janaka De Silva
Hithanadura Janaka De Silva

15 September 2021 in Journal of the Postgraduate Institute of Medicine
Verified
Journal Article
Open access
PDF file
AHAruni Hapangama
Aruni Hapangama
DDD.G.B.M S Dasanyake
D.G.B.M S Dasanyake
KKK A L A Kuruppuarachchi
K A L A Kuruppuarachchi
APA Pathmeswaran
A Pathmeswaran
HSHithanadura Janaka De Silva
Hithanadura Janaka De Silva

4 May 2022 in Ceylon Medical Journal
Verified
Journal Article
Open access
PDF file
MNMadunil Anuk Niriella
Madunil Anuk Niriella
ADAnuradha Dassanayake
Anuradha Dassanayake
HSHithanadura Janaka De Silva
Hithanadura Janaka De Silva

9 May 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
ASArjuna P De Silva
Arjuna P De Silva
NNNilushi Nuwanshika
Nilushi Nuwanshika
MNMadunil Anuk Niriella
Madunil Anuk Niriella
HSHithanadura Janaka De Silva
Hithanadura Janaka De Silva
Gilbert's syndrome (GS) is a common hereditary condition characterized by mild increases in serum bilirubin levels due to inherited defects in bilirubin metabolism. This review, based on data from peer-reviewed articles and journals spanning from 1977 to January 2024, provides a comprehensive overview of over four decades of research on GS. Early studies primarily focused on defining the clinical and genetic characteristics of the syndrome, laying the foundation for subsequent investigations. More recent research has delved into the genetic mechanisms underlying the reduced expression of bilirubin UDP-glucuronosyltransferase, which has significantly enhanced our understanding of the pathogenesis of GS. Furthermore, recent studies have shed light on the clinical implications of GS, including its association with non-alcoholic fatty liver disease and mortality risk, highlighting the complex interplay between genetic factors, bilirubin metabolism, and clinical outcomes. Despite its generally benign nature, thorough research is essential to fully understand the impact of GS on patients' lives. This review emphasizes the importance of ongoing research to deepen our understanding of GS and its broader implications.